Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson
Huberman Lab
This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the clinical trials in his lab are revealing about the potential these compounds hold for the treatment of depression, addiction, trauma, eating disorders, ADHD, and other disorders of the mind. Dr. Johnson describes a typical psychedelic experiment in his laboratory, start to finish, including the conditions for optimal clinical outcomes. And he explains some of the potential hazards and common misconceptions and pitfalls related to psychedelic medicine. Dr. Johnson explains flashbacks, the heightened risks of certain people and age groups using psychedelics and the ever evolving legal and pharmaceutical industry landscape surrounding psychedelics. Dr. Johnson also explains how the scientific study of psychedelics is likely to set the trajectory of psychiatric medicine in the years to come. Dr. Johnson is among a small handful of researchers who have pioneered the clinical study of these powerful compounds. He has unprecedented insight into how they can be woven into other psychiatric treatments, changing ones sense of self and of reality.
Read the full show notes for this episode at hubermanlab.com.
Thank you to our sponsors
AG1: athleticgreens.com/huberman
LMNT: drinklmnt.com/hubermanlab
Waking Up: wakingup.com/huberman
Momentous: livemomentous.com/huberman
00:00:00 Introducing Dr. Matthew Johnson
00:02:27 Sponsors: AG1, LMNT & Waking Up
00:14:09 Hallucinations, Synesthesia, Altered Space-Time Perception
00:19:56 Serotonin & Dopamine
00:23:50 Ketamine & Glutamate
00:28:00 An Example Psychedelic Experiment
00:44:10 Our Mind’s Eye
00:48:00 Redefining Your Sense of Self
00:58:56 Exporting Psychedelic Learnings to Daily Life
01:04:36 Flashbacks
01:12:10 Ayahuasca, ASMR, Kundalini Breathing
01:15:54 MDMA, DMT
01:26:00 Dangers of Psychedelics, Bad Trips, Long-Lasting Psychosis
01:38:15 Micro-Dosing
01:56:45 Risks for Kids, Adolescents & Teenagers; Future Clinical Trials
02:03:40 Legal Status: Decriminalization vs. Legalization vs. Regulation
02:18:35 Psychedelics for Treating Concussion & Traumatic Brain Injury
02:27:45 Shifting Trends in Psychedelic Research, Academic Culture
02:44:23 Participating in a Clinical Trial, Online Survey Studies, Breathwork
02:50:38 Conclusions, Subscribing & Supporting the HLP, Supplements
Learn more about your ad choices. Visit megaphone.fm/adchoices
Raw Description
<p>This episode I discuss medical research on psychedelic compounds with <a href="https://www.sheppardpratt.org/why-sheppard-pratt/our-experts/details/matthew-w-johnson-phd/">Dr. Matthew Johnson, Ph.D.</a>, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the clinical trials in his lab are revealing about the potential these compounds hold for the treatment of depression, addiction, trauma, eating disorders, ADHD, and other disorders of the mind. Dr. Johnson describes a typical psychedelic experiment in his laboratory, start to finish, including the conditions for optimal clinical outcomes. And he explains some of the potential hazards and common misconceptions and pitfalls related to psychedelic medicine. Dr. Johnson explains flashbacks, the heightened risks of certain people and age groups using psychedelics and the ever evolving legal and pharmaceutical industry landscape surrounding psychedelics. Dr. Johnson also explains how the scientific study of psychedelics is likely to set the trajectory of psychiatric medicine in the years to come. Dr. Johnson is among a small handful of researchers who have pioneered the clinical study of these powerful compounds. He has unprecedented insight into how they can be woven into other psychiatric treatments, changing ones sense of self and of reality.</p><p>Read the full show notes for this episode at <a href="https://www.hubermanlab.com/episode/dr-matthew-johnson-psychedelic-medicine">hubermanlab.com</a>.</p><h2>Thank you to our sponsors</h2><p>AG1: <a href="https://athleticgreens.com/huberman">https://athleticgreens.com/huberman</a></p><p>LMNT: <a href="https://go.hubermanlab.com/lmnt-back-catalog">https://drinklmnt.com/hubermanlab</a></p><p>Waking Up: <a href="https://wakingup.com/huberman">https://wakingup.com/huberman</a></p><p>Momentous: <a href="https://livemomentous.com/huberman">https://livemomentous.com/huberman</a></p><h2>Timestamps</h2><p>00:00:00 Introducing Dr. Matthew Johnson </p><p>00:02:27 Sponsors: AG1, LMNT & Waking Up</p><p>00:06:40 ‘Psychedelics’ Defined </p><p>00:14:09 Hallucinations, Synesthesia, Altered Space-Time Perception </p><p>00:19:56 Serotonin & Dopamine </p><p>00:23:50 Ketamine & Glutamate </p><p>00:28:00 An Example Psychedelic Experiment </p><p>00:37:30 ‘Letting Go’ with Psychedelics </p><p>00:44:10 Our Mind’s Eye </p><p>00:48:00 Redefining Your Sense of Self </p><p>00:58:56 Exporting Psychedelic Learnings to Daily Life </p><p>01:04:36 Flashbacks </p><p>01:12:10 Ayahuasca, ASMR, Kundalini Breathing </p><p>01:15:54 MDMA, DMT </p><p>01:26:00 Dangers of Psychedelics, Bad Trips, Long-Lasting Psychosis </p><p>01:38:15 Micro-Dosing </p><p>01:56:45 Risks for Kids, Adolescents & Teenagers; Future Clinical Trials </p><p>02:03:40 Legal Status: Decriminalization vs. Legalization vs. Regulation </p><p>02:18:35 Psychedelics for Treating Concussion & Traumatic Brain Injury </p><p>02:27:45 Shifting Trends in Psychedelic Research, Academic Culture </p><p>02:44:23 Participating in a Clinical Trial, Online Survey Studies, Breathwork </p><p>02:50:38 Conclusions, Subscribing & Supporting the HLP, Supplements </p><p><a href="https://www.hubermanlab.com/disclaimer">Disclaimer & Disclosures</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>
Chapters (1/22)
Show Notes
This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the clinical trials in his lab are revealing about the potential these compounds hold for the treatment of depression, addiction, trauma, eating disorders, ADHD, and other disorders of the mind. Dr. Johnson describes a typical psychedelic experiment in his laboratory, start to finish, including the conditions for optimal clinical outcomes. And he explains some of the potential hazards and common misconceptions and pitfalls related to psychedelic medicine. Dr. Johnson explains flashbacks, the heightened risks of certain people and age groups using psychedelics and the ever evolving legal and pharmaceutical industry landscape surrounding psychedelics. Dr. Johnson also explains how the scientific study of psychedelics is likely to set the trajectory of psychiatric medicine in the years to come. Dr. Johnson is among a small handful of researchers who have pioneered the clinical study of these powerful compounds. He has unprecedented insight into how they can be woven into other psychiatric treatments, changing ones sense of self and of reality.
Read the full show notes for this episode at hubermanlab.com.
Thank you to our sponsors
AG1: athleticgreens.com/huberman
LMNT: drinklmnt.com/hubermanlab
Waking Up: wakingup.com/huberman
Momentous: livemomentous.com/huberman
00:00:00 Introducing Dr. Matthew Johnson
00:02:27 Sponsors: AG1, LMNT & Waking Up
00:14:09 Hallucinations, Synesthesia, Altered Space-Time Perception
00:19:56 Serotonin & Dopamine
00:23:50 Ketamine & Glutamate
00:28:00 An Example Psychedelic Experiment
00:44:10 Our Mind’s Eye
00:48:00 Redefining Your Sense of Self
00:58:56 Exporting Psychedelic Learnings to Daily Life
01:04:36 Flashbacks
01:12:10 Ayahuasca, ASMR, Kundalini Breathing
01:15:54 MDMA, DMT
01:26:00 Dangers of Psychedelics, Bad Trips, Long-Lasting Psychosis
01:38:15 Micro-Dosing
01:56:45 Risks for Kids, Adolescents & Teenagers; Future Clinical Trials
02:03:40 Legal Status: Decriminalization vs. Legalization vs. Regulation
02:18:35 Psychedelics for Treating Concussion & Traumatic Brain Injury
02:27:45 Shifting Trends in Psychedelic Research, Academic Culture
02:44:23 Participating in a Clinical Trial, Online Survey Studies, Breathwork
02:50:38 Conclusions, Subscribing & Supporting the HLP, Supplements
Learn more about your ad choices. Visit megaphone.fm/adchoices
Raw Description
<p>This episode I discuss medical research on psychedelic compounds with <a href="https://www.sheppardpratt.org/why-sheppard-pratt/our-experts/details/matthew-w-johnson-phd/">Dr. Matthew Johnson, Ph.D.</a>, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the clinical trials in his lab are revealing about the potential these compounds hold for the treatment of depression, addiction, trauma, eating disorders, ADHD, and other disorders of the mind. Dr. Johnson describes a typical psychedelic experiment in his laboratory, start to finish, including the conditions for optimal clinical outcomes. And he explains some of the potential hazards and common misconceptions and pitfalls related to psychedelic medicine. Dr. Johnson explains flashbacks, the heightened risks of certain people and age groups using psychedelics and the ever evolving legal and pharmaceutical industry landscape surrounding psychedelics. Dr. Johnson also explains how the scientific study of psychedelics is likely to set the trajectory of psychiatric medicine in the years to come. Dr. Johnson is among a small handful of researchers who have pioneered the clinical study of these powerful compounds. He has unprecedented insight into how they can be woven into other psychiatric treatments, changing ones sense of self and of reality.</p><p>Read the full show notes for this episode at <a href="https://www.hubermanlab.com/episode/dr-matthew-johnson-psychedelic-medicine">hubermanlab.com</a>.</p><h2>Thank you to our sponsors</h2><p>AG1: <a href="https://athleticgreens.com/huberman">https://athleticgreens.com/huberman</a></p><p>LMNT: <a href="https://go.hubermanlab.com/lmnt-back-catalog">https://drinklmnt.com/hubermanlab</a></p><p>Waking Up: <a href="https://wakingup.com/huberman">https://wakingup.com/huberman</a></p><p>Momentous: <a href="https://livemomentous.com/huberman">https://livemomentous.com/huberman</a></p><h2>Timestamps</h2><p>00:00:00 Introducing Dr. Matthew Johnson </p><p>00:02:27 Sponsors: AG1, LMNT & Waking Up</p><p>00:06:40 ‘Psychedelics’ Defined </p><p>00:14:09 Hallucinations, Synesthesia, Altered Space-Time Perception </p><p>00:19:56 Serotonin & Dopamine </p><p>00:23:50 Ketamine & Glutamate </p><p>00:28:00 An Example Psychedelic Experiment </p><p>00:37:30 ‘Letting Go’ with Psychedelics </p><p>00:44:10 Our Mind’s Eye </p><p>00:48:00 Redefining Your Sense of Self </p><p>00:58:56 Exporting Psychedelic Learnings to Daily Life </p><p>01:04:36 Flashbacks </p><p>01:12:10 Ayahuasca, ASMR, Kundalini Breathing </p><p>01:15:54 MDMA, DMT </p><p>01:26:00 Dangers of Psychedelics, Bad Trips, Long-Lasting Psychosis </p><p>01:38:15 Micro-Dosing </p><p>01:56:45 Risks for Kids, Adolescents & Teenagers; Future Clinical Trials </p><p>02:03:40 Legal Status: Decriminalization vs. Legalization vs. Regulation </p><p>02:18:35 Psychedelics for Treating Concussion & Traumatic Brain Injury </p><p>02:27:45 Shifting Trends in Psychedelic Research, Academic Culture </p><p>02:44:23 Participating in a Clinical Trial, Online Survey Studies, Breathwork </p><p>02:50:38 Conclusions, Subscribing & Supporting the HLP, Supplements </p><p><a href="https://www.hubermanlab.com/disclaimer">Disclaimer & Disclosures</a></p><p> </p><p>Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a></p>